Accelerating treatments and cures by fostering communication, cooperation and collaborations among researchers and institutions.
CANCollaborate is a non-profit 501(c)(3) dedicated to fostering communication, cooperation and collaborations among researchers and institutions with the goal of accelerating treatments and cures for diseases.
While we began with a focus on rare cancers, our efforts are now relevant to all areas of research.
Our Approach
Developing a Collaborative Model
CANCollaborate aims to develop and optimize a collaborative model that brings together disruptive thinkers, leading researchers and innovators. This model is designed to consolidate expertise, facilitate data and model sharing - ensuring a more comprehensive approach to research.
Disrupting the Financial Traditions
Despite significant scientific breakthroughs, too few discoveries are translated into treatments. Many investors, private and public withhold funding due to much risk and uncertainty. We hope to create new business models and financing structures that can reduce risks and provide greater rewards.
A Vision for the Future
By pioneering such collaborations, CANCollaborate is addressing the immediate challenges of rare cancers and also laying the groundwork for a brighter future in all diseases.
Our beginnings
Steve Wallman, a lawyer, finance expert, entrepreneur, and former commissioner of the US Securities and Exchange Commission, had no personal connection to cancer or healthcare. That is until his wife, Kathy, a brilliant lawyer and writer—who seemed completely healthy—was diagnosed with stage 4 appendiceal cancer following a routine physical exam.
Working with Professor Andrew W. Lo from Laboratory for Financial Engineering, MIT and Jane Wilkinson from the MIT Koch Institute for Integrative Cancer Research, they gathered experts in cancer research, rare disease research, regulatory, government policy, and finance policy for a 2 day workshop in April 2023. A spark was ignited and a shared commitment to solve the challenges of appendiceal and other rare cancer was born. CANCollaborate was created in September 2023.
Mission Areas
-
We will develop and manage collaborative projects across leading researchers and innovators. Our proven experience in managing complex scientific projects will allow our research partners to focus on the innovation.
-
We will create a place for researchers to communicate and share their discoveries through workshops, calls and conference meet-ups. We will focus on concise and impactful communication channels.
-
We will be disruptive - we will create new business models and financing structures that can reduce risks and provide rewards.
-
We will create a vibrant network of diverse thinkers and strategists working across disciplines to build on the foundational knowledge of rare cancers.
-
We will facilitate data sharing - highlighting discoveries and innovations across our network of researchers and we will strongly support open access to data.
-
Contact us to be a part of our research collaboration network.
-
Talk to us about how we can partner on creating new funding opportunities and strategies.
-
Stay in touch and learn about our research updates and how we are improving the understanding of disease.
-
Join us in a conversation about creating a vibrant network of thinkers and strategists